Brigatinib

Generic name: Brigatinib
Brand names: Alunbrig
Dosage form: oral tablet (180 mg; 30 mg; 90 mg; 90 mg-180 mg)
Drug class: Multikinase inhibitors

Usage of Brigatinib

Brigatinib is used to treat non-small cell lung cancer that has spread to other parts of the body (metastatic) after other treatments have failed.

Brigatinib is used only if your cancer has a specific genetic marker (an abnormal "ALK" gene). Your doctor will test you for this gene.

Brigatinib may also be used for purposes not listed in this medication guide.

Brigatinib side effects

Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Brigatinib may cause serious side effects. Call your doctor at once if you have:

lung problems--cough, trouble breathing, chest pain, fever;

vision problems--blurred vision, double vision, increased sensitivity to light, seeing flashes of light or "floaters" in your vision;

high blood pressure--severe headache, pounding in your neck or ears, dizziness;

high blood sugar--increased thirst, increased urination, hunger, nausea, fruity breath odor, weakness, confusion;

heart problems--very slow heartbeats, feeling like you might pass out;

muscle problems--unexplained muscle pain or weakness; or

pancreatitis--upper stomach pain (worse with eating and may spread to your back), nausea, weight loss.

Your cancer treatments may be delayed or permanently discontinued if you have certain side effects.

Common side effects of brigatinib may include:

nausea, vomiting, diarrhea;

increased blood pressure;

trouble breathing;

cough;

rash;

muscle pain;

headache; or

feeling tired.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Before taking Brigatinib

You should not use brigatinib if you are allergic to it.

Tell your doctor if you have ever had:

lung disease or breathing problems;

slow heartbeats;

high blood pressure;

vision problems;

diabetes or glucose intolerance;

pancreas problems;

liver disease; or

kidney disease (or if you are on dialysis).

You may need to have a negative pregnancy test before starting this treatment.

Brigatinib can harm an unborn baby if the mother or the father is using brigatinib.

If you are a woman, do not use this medicine if you are pregnant. Brigatinib can make hormonal birth control less effective, including birth control pills, injections, implants, skin patches, and vaginal rings. Use an effective non-hormonal form of birth control such as an intrauterine device (IUD). Avoid getting pregnant for at least 4 months after your last dose.

If you are a man, use condoms or other barrier birth control if your sex partner is able to get pregnant. Keep using condoms for at least 3 months after your last dose.

Tell your doctor right away if a pregnancy occurs while either the mother or the father is using brigatinib.

This medicine may affect fertility (ability to have children) in men. However, it is important to use birth control to prevent pregnancy because brigatinib can harm an unborn baby.

Do not breastfeed while using this medicine, and for at least 1 week after your last dose.

Relate drugs

How to use Brigatinib

Usual Adult Dose for Non-Small Cell Lung Cancer:

Initial dose: 90 mg orally once a day for the first 7 daysMaintenance dose: 180 mg orally once a dayComments:-Patients should be selected for the treatment of metastatic NSCLC based on the presence of ALK positivity in tumor specimens.-FDA-approved test for the detection of ALK rearrangements in NSCLC is available at http://www.fda.gov/CompanionDiagnostic-Treatment should be continued until disease progression or unacceptable toxicity.Use: For treatment of patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) as detected by an FDA-approved test

Warnings

Brigatinib can cause serious side effects such as lung problems, vision problems, high blood pressure, high blood sugar, very slow heartbeats, muscle damage, or pancreatitis.

Call your doctor at once if you have side effects, such as: severe headache, confusion, feeling light-headed, blurred vision, seeing flashes of light or "floaters" in your vision, increased thirst or urination, hunger, nausea, upper stomach pain spreading to your back, unexplained muscle pain or weakness, fever, cough, chest pain, trouble breathing, very slow heartbeats, or feeling like you might pass out.

What other drugs will affect Brigatinib

Sometimes it is not safe to use certain medications at the same time. Some drugs can affect your blood levels of other drugs you take, which may increase side effects or make the medications less effective.

Many drugs can affect brigatinib. This includes prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible interactions are listed here. Tell your doctor about all your current medicines and any medicine you start or stop using.

Popular FAQ

Yes, Alunbrig is the brand name product for brigatinib, a medicine used to treat non-small cell lung cancer that has spread in the body. Alunbrig, from Takeda Pharmaceuticals, was first approved in April 2017. There is no generic alternative for Alunbrig at this time.

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.